TCTMD’s Top 10 Most Popular Stories for July 2019
Valves, inducible ischemia, an “urgent field notice,” SCOTHEART, and more SCCT news are among the month’s top stories.
Valves dominated the most-popular list this month, topped by a story about the urgent field notice sent by Edwards Lifesciences alerting operators to reports of burst balloons with the Sapien 3 Ultra. Other stories looked at valve positioning and future coronary access, fragmented TAVR care, life expectancy after SAVR, and MitraClip volumes. Among the top 3 was a 10-year follow-up study from MASS II addressing the link between inducible ischemia and CV outcomes, which in the words of one expert, serves to build “suspense” for the ISCHEMIA trial. Stories from the SCCT 2019 meeting, held earlier this month, round out the list.
Edwards Lifesciences alerted operators about reports of burst balloons that have led to complications in retrieving the delivery system.
It may be possible to deploy the valve in a coronary-access friendly position, experts say.
Ischemia on exercise predicted neither MACE nor LV function changes in this long-running trial. Suspense builds for ISCHEMIA.
SCOT-HEART results are boosting CT use, at least in the UK, but many still question how an imaging test could reduce events.
Living farther way and needing to drive longer were found to significantly increase care fragmentation.
Consumers “appeared to be the most susceptible to the widely covered recall, [but] healthcare providers were also influenced,” researchers found.
Knowing more about survival rates can help inform decision-making for physicians and patients, experts say.
The institutional learning curve was evident up until 50 cases, but improvements were observed up to 200 procedures.
Making the pathway to prescription less burdensome for the highest-risk patients could maximize benefit, experts argue.
Hematuria is tied to an increase in ED visits and hospital admissions, and may even be a sign of otherwise silent bladder cancer.
This month we re-launched our Off Script physician blog, with insights from Sahil Parikh, MD, on the recent FDA advisory panel meeting.
Fellow Talk: Hemodynamics—the Forgotten Branch of Cardiology
Mesfer Alfadhel, MD, asks: given advancements in the field, is it time for fellows to spend more time learning how to do advanced hemodynamics?